The NF-κB signaling pathway controls the expression of numerous genes that regulate cell proliferation, stress responses, and apoptosis.26 Inhibiting NF-κB signaling has potential therapeutic applications in cancer therapy.27 The docking result provides a compelling reason to develop this new compound (CCA-1.1) as an anticancer agent. The gene discussed is NFKB1; the disease is cancer.